New Delhi: The COVID-19 vaccine developed by Oxford University and AstraZeneca give good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford’s vaccine trial chief Andrew Pollard said on Wednesday, News18 reported.
“The point is that we have rather less data in older adults, which is why people have less certainty about the level of protection,” Pollard told BBC radio.
“But we have good immune responses in older adults very similar to younger adults, the protection that we do see is in exactly the same direction, and of a similar magnitude.”
Pollard said different countries would recommend that the shot is used in different contexts after France’s top health body recommended it only be given to people under 65. But he pointed out the EU regulator had approved it for all ages, the report added.
Bhubaneswar: The Central Bureau of Investigation (CBI) has arrested Divisional Railway Manager (Waltair Division), Visakhapatnam,…
Bhunbaneswar: Vigilance sleuths on Monday launched simultaneous raids at four places linked to Subash Chandra…
Bhubaneswar: The 10th National Children’s Literary Festival 2024 at KIIT International School began on a…
Bhubaneswar: Dr Achyuta Samanta, the Founder of KIIT and KISS, has been conferred the prestigious…
Sambalpur: In a tragic incident, three elephants died reportedly due to electrocution after coming in…
New Delhi: Amid reports that Ayatollah Ali Khamenei is seriously ill, the Iranian supreme leader…
New Delhi: The air pollution level in the national capital reached the ‘severe plus’ category…
Why Chilika's Irrawaddy dolphin population matters On the surface, the Irrawaddy dolphin appears to be…